DM 002
Alternative Names: DM-002Latest Information Update: 21 Jun 2023
At a glance
- Originator Doma Bio
- Developer Beijing Biocytogen; Doma Bio
- Class Antineoplastics; Auristatins; Bispecific antibodies; Drug conjugates; Immunotoxins
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Solid tumours